U.S. Terminates Funding for Polio, H.I.V., Malaria and Nutrition Programs Around the World

U.S. Terminates Funding for Polio, H.I.V., Malaria and Nutrition Programs Around the World
U.S. Terminates Funding for Polio, H.I.V., Malaria and Nutrition Programs Around the World

Advertisement

SKIP ADVERTISEMENT

You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load.

Here are some of the 5,800 contracts the Trump administration formally canceled this week in a wave of terse emails.

A woman in a patterned dress sits in front of wallpaper with the U.S.A.I.D. logo. Two other women and two children sit to her right.
Women listen to a public health educator during an mpox awareness campaign at the Muja camp for the internally displaced near Goma in the Democratic Republic of Congo last year.Credit…Arlette Bashizi/Reuters

Starting Wednesday afternoon, a wave of emails went out from the State Department in Washington around the world, landing in inboxes for refugee camps, tuberculosis clinics, polio vaccination projects and thousands of other organizations that received crucial funding for lifesaving work.

“This award is being terminated for convenience and the interest of the U.S. government,” they began.

The terse notes ended funding for some 5,800 projects that had been financed by the United States Agency for International Development, indicating that a tumultuous period when the Trump administration said it was freezing projects for ostensible review was over, and that any faint hope American assistance might continue had ended.

Many were projects that had received a waiver from the freeze because the State Department previously identified its work as essential and lifesaving.

“People will die,” said Dr. Catherine Kyobutungi, executive director of the African Population and Health Research Center, “but we will never know, because even the programs to count the dead are cut.”


Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.


Thank you for your patience while we verify access.

Already a subscriber? Log in.

Want all of The Times? Subscribe.

Advertisement

SKIP ADVERTISEMENT

Read More